Publications by authors named "Aristides Polyzos"

Claim this Profile
W
Weekly Gemcitabine plus Fluorouracil-Folinic Acid Given Weekly for Two Days in Patients with Advanced Pancreatic Cancer : A Phase II Study.
Aristides Polyzos, Nicholas Tsavaris, Christos Kosmas, Helen Gogas, George Koutinos

Clin Drug Investig· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified docetaxel-cisplatin in combination with capecitabine as first-line treatment in metastatic gastric cancer. a phase II study.
Aristides Polyzos, Evangellos Felekouras, Theodore Karatzas, John Griniatsos, Dimitrios Dimitroulis, Kostas Polyzos

Anticancer Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer.
Zacharenia Saridaki, Nikolaos Malamos, Panagiotis Kourakos, Aristides Polyzos, Alexandros Ardavanis

Cancer Chemother Pharmacol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG).
Aristides Polyzos, Nikolaos Malamos, Ioannis Boukovinas, Adamos Adamou, Nikolaos Ziras

Breast Cancer Res Treat· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin-Ifosfamide-gemcitabine as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and Paclitaxel.
Aristides Polyzos, Nikolas Tsavaris, Helen Gogas, Antonios Lagadas, Kostas Polyzos

Anticancer Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage chemotherapy with oxaliplatin and capecitabine for breast cancer patients pretreated with anthracyclines and taxanes.
Aristides Polyzos, Helen Gogas, Christos Markopoulos, Nikolas Tsavaris, Othon Papadopoulos, Kostas Polyzos

Anticancer Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance.
Zacharoula Panteleakou, Peter Lembessis, Antigone Sourla, Nikolaos Pissimissis, Aristides Polyzos

Mol Med· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
Aristides Polyzos, Nikolas Tsavaris, Hellen Gogas, John Souglakos, Lambros Vambakas, Kostas Polyzos

Oncology· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.
Aristides Polyzos, Christos Kosmas, Nikolas Tsavaris, Helen Toufexi, Antonios Lagadas

Anticancer Res· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel-cisplatin.
Aristides Polyzos, Nikolas Tsavaris, Christos Kosmas, Kostas Polyzos, Athanasios Giannopoulos

Anticancer Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel in combination with irinotecan (CPT-11) in platinum-resistant paclitaxel-pretreated ovarian cancer.
Aristides Polyzos, Christos Kosmas, Helen Toufexi, Nicholas Malamos, Antonios Lagadas

Anticancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of weekly docetaxel with a 4-weekly cisplatin administration in patients with advanced gastric carcinoma.
Aristides Polyzos, Konstantinos Syrigos, John Stergiou, Christos Panopoulos, Anna Potamianou

Cancer Chemother Pharmacol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel and epirubicin supported by granulocyte colony-stimulating factor first-line in advanced breast cancer.
Aristides Polyzos, Nicholas Tsavaris, Christos Kosmas, Helen Gogas, Maria Vadiaka

Anticancer Res· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis